Breast Cancer and Its Relationship with the Microbiota
Open accessThe DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
The microorganisms that live symbiotically in human beings are increasingly recognized as important players in health and disease. The largest collection of these microorganisms is found in the gastrointestinal tract. Microbial composition reflects both genetic and lifestyle variables of the host. This microbiota is in a dynamic balance with the host, exerting local and distant effects. Microbial perturbation (dysbiosis) could contribute to the risk of developing health problems. Various bacterial genes capable of producing estrogen-metabolizing enzymes have been identified. Accordingly, gut microbiota is capable of modulating estrogen serum levels. Conversely, estrogen-like compounds may promote the proliferation of certain species of bacteria. Therefore, a crosstalk between microbiota and both endogenous hormones and estrogen-like compounds might synergize to provide protection from disease but also to increase the risk of developing hormone-related diseases. Recent research suggests that the microbiota of women with breast cancer differs from that of healthy women, indicating that certain bacteria may be associated with cancer development and with different responses to therapy. In this review, we discuss recent knowledge about the microbiome and breast cancer, identifying specific characteristics of the human microbiome that may serve to develop novel approaches for risk assessment, prevention and treatment for this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, this sudden rise in estrogen increases the risk of developing breast cancer [436].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [436]
Experimental — accuracy not yet measuredIn the citing paper
“Accordingly, this augmented intake of estrogen hormones is linked with an increased risk of developing breast cancer, supporting the finding that the gut microbiota composition of women with breast cancer differs from that from healthy controls, and suggesting that several gut bacteria, which could be over-expressed during dysbiosis, may be linked with breast cancer development [83].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [83]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Subbaramaiah, K., Morris, P. G., Zhou, X. K., Morrow, M., Du, B., Giri, D., Kopelovich, L., Hudis, C. A., & Dannenberg, A. J. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0241 · Cited by 244
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
DADA2: High–resolution sample inference from Illumina amplicon data
Callahan, B. J., McMurdie, P. J., Rosen, M. J., Han, A. W., Johnson, A. J. A., & Holmes, S. P. (2016) · Nature Methods · doi:10.1038/nmeth.3869 · Cited by 35,698
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 2×
“The gut microbiota has been also related to the development of adiposity and obesity [55], and it is known that overweight and obese women have a higher risk of BC compared to healthy weight women, especially during the postmenopausal period [56].”
Background
Cited by
Items 101–200 of 356
Impact of intestinal dysbiosis on breast cancer metastasis and progression
Zhang, J., Xie, Q., Huo, X., Liu, Z., Da, M., Yuan, M., Zhao, Y. D., & Shen, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1037831 · Cited by 35
Nearing, J. T., DeClercq, V., & Langille, M. G. I. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00391-7 · Cited by 36
Breast Cancer: Extracellular Matrix and Microbiome Interactions
Herrera‐Quintana, L., Vázquez‐Lorente, H., & Plaza‐Díaz, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137226 · Cited by 36
Self-citationRastogi, Y. R., Saini, A. K., Thakur, V. K., & Saini, R. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093212 · Cited by 35
The intratumoural microbiota in cancer: new insights from inside
An, Y., Zhang, W., Liu, T., Wang, B., & Cao, H. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188626 · Cited by 29
van Die, M. D., Bone, K. M., Visvanathan, K., Kyrø, C., Aune, D., Ee, C., & Paller, C. J. (2023) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkad104 · Cited by 34
Smith, K. S., Frugé, A. D., Pol, W. V. D., Caston, N. E., Morrow, C. D., Demark‐Wahnefried, W., & Carson, T. L. (2021) · Beneficial Microbes · doi:10.3920/bm2020.0098 · Cited by 29
Laborda-Illanes, A., Sánchez-Alcoholado, L., Boutriq, S., Plaza-Andrades, I., Peralta-Linero, J., Alba, E., González-González, A., & Queipo-Ortuño, M. I. (2021) · Cancers · doi:10.3390/cancers13133141 · Cited by 28
“In a study by Fernández et al., breast cancer patients presented a greater abundance of Clostridiales, Ruminococcaceae, Faecalibacterium, Escherichia coli and Shigella [59], capable of reactivating estrogens by deconjugation through their β-glucosidase and β-glucuronidase (GUS genes [53]) activity [55,60].”
BackgroundInfluentialBacterial extracellular vesicles affect endocrine therapy in MCF7 cells
An, J., Kim, J. B., Yang, E. Y., Kim, H. O., Lee, W.-H., Yang, J., Kwon, H., Paik, N. S., Lim, W., Kim, Y., et al. (2021) · Medicine · doi:10.1097/md.0000000000025835 · Cited by 28
You, L., Zhou, J., Xin, Z., Hauck, J. S., Na, F., Tang, J., Zhou, X., Lei, Z., & Ying, B. (2022) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbac005 · Cited by 35
Shi, Q. W., Wang, J., Zhou, M., Zheng, R., Zhang, X., & Liu, B. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111039 · Cited by 34
Gut Microbiota and Immune Responses
Dong, L., Xie, J., Wang, Y., & Zuo, D. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2385-4_10 · Cited by 31
Lahiji, M. R., Najafi, S., Janani, L., Yazdani, B., Razmpoosh, E., & Zarrati, M. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.05.043 · Cited by 29
From Nature to Nanotechnology: The Bioactivities of Mangiferin Explored
Al-Madhagi, H. (2025) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s525423 · Cited by 26
“37,38 Given the strong connection between inflammation and cancer, targeting the pathway leading to inflammatory factors blockade and, at the same time, inhibiting cancer initiation, progression and even metastasis, these theragnostic tools can play a crucial role in cancer management.”
Toumazi, D., Daccache, S. E., & Constantinou, C. (2021) · Oncology Reports · doi:10.3892/or.2021.8031 · Cited by 32
Lasagna, A., AMICI, M. D., Rossi, C., Zuccaro, V., Corbella, M., Petazzoni, G., Comandatore, F., Sacchi, L., Testa, G., Ferraris, E., et al. (2022) · Pathogens · doi:10.3390/pathogens11121421 · Cited by 28
Chakraborty, P., Aravindhan, V., & Mukherjee, S. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124649 · Cited by 29
Chapadgaonkar, S. S., Bajpai, S., & Godbole, M. S. (2023) · Cancer Reports · doi:10.1002/cnr2.1847 · Cited by 41
The antigenic link between thyroid autoimmunity and breast cancer
Muller, I., & Barrett-Lee, P. J. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.05.013 · Cited by 27
The menstrual cycle may not be limited to the endometrium but also may impact gut permeability
Roomruangwong, C., Carvalho, A. F., Geffard, M., & Maes, M. H. J. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.30 · Cited by 28
Association between Gut Microbiota and Breast Cancer: Diet as a Potential Modulating Factor
Dindar, D. A., Chun, B., Palma, A., Cheney, J., Krieger, M., Kasschau, K. D., Stagaman, K., Mitri, Z. I., Goodyear, S. M., Shannon, J., et al. (2023) · Nutrients · doi:10.3390/nu15214628 · Cited by 29
Rubidium chloride modulated the fecal microbiota community in mice
Chen, Q., He, Z., Zhuo, Y., Li, S., Yang, W., Hu, L., & Zhong, H. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02095-4 · Cited by 26
Silva, S. D., Tennekoon, K. H., & Karunanayake, E. H. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s329383 · Cited by 24
Hong, J., He, Y., Fu, R., Si, Y.-X., Xu, B., Xu, J., Li, X., & Mao, F. (2022) · Open Medicine · doi:10.1515/med-2022-0470 · Cited by 37
Gupta, I., Pedersen, S., Vranić, S., & Moustafa, A. A. (2022) · Cancers · doi:10.3390/cancers14122964 · Cited by 27
Amaro-da-Cruz, A., Rubio‐Tomás, T., & Álvarez‐Mercado, A. I. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03554-w · Cited by 26
Yoon, H., Kim, H., Bang, J.-I., Lim, W., Moon, B.-I., Paik, N. S., Kim, B. S., & Kim, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-54680-3 · Cited by 20
Gut microbiota homeostasis restoration may become a novel therapy for breast cancer
Feng, Z., Xin, H.-Y., Zhang, Z., Liu, C., Yang, Z., You, H., & Xin, H.-W. (2021) · Investigational New Drugs · doi:10.1007/s10637-021-01063-z · Cited by 23
The crosstalk of the human microbiome in breast and colon cancer: A metabolomics analysis
Mukherjee, A. G., Wanjari, U. R., Bradu, P., Murali, R., Kannampuzha, S., Loganathan, T., Doss, C. G. P., Arun Prakash, B. P., Renu, K., Dey, A., et al. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103757 · Cited by 23
Metagenomics Analysis of Breast Microbiome Highlights the Abundance of Rothia Genus in Tumor Tissues
Kartti, S., Bendani, H., Boumajdi, N., Bouricha, E. M., Zarrik, O., Agouri, H. E., Fokar, M., Aghlallou, Y., Jaoudi, R. E., Belyamani, L., et al. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030450 · Cited by 22
Mao, W., Mao, L., Zhou, F., Shen, J., Zhao, N., Jin, H., Hu, J. S., & Hu, Z. (2023) · Toxics · doi:10.3390/toxics11040340 · Cited by 25
Schettini, F., Gattazzo, F., Nucera, S., Rubio-García, E., López-Aladid, R., Morelli, L., Fontana, A., Vigneri, P. G., Casals‐Pascual, C., Iebba, V., et al. (2024) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2024.102816 · Cited by 25
Microbiome modulation of tumorigenesis and immune responses
Chen, Y., Fang, Y., Lyu, Z., Tian, Y., Niu, S., Li, Y.-R., & Yang, L. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-025-01208-9 · Cited by 30
Potential of the Microbiome as a Biomarker for Early Diagnosis and Prognosis of Breast Cancer
Jarman, R., Ribeiro-Milograna, S., & Kalle, W. H. J. (2020) · Journal of Breast Cancer · doi:10.4048/jbc.2020.23.e60 · Cited by 24
Impact of microbiota on breast cancer hormone therapy
Terrisse, S. A., Zitvogel, L., & Kroemer, G. (2023) · Cell Stress · doi:10.15698/cst2023.03.277 · Cited by 22
Laivacuma, S., Oblate, O., & Derovs, A. (2025) · Microorganisms · doi:10.3390/microorganisms13051053 · Cited by 25
Summer, M., Sajjad, A., Ali, S., & Hussain, T. (2024) · Archives of Microbiology · doi:10.1007/s00203-024-03868-x · Cited by 22
New Developments and Opportunities of Microbiota in Treating Breast Cancers
Meng, Z., Ye, Z., Zhu, P., Zhu, J., Fang, S., Qiu, T., Li, Y., & Meng, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.818793 · Cited by 19
Cui, J., Sachaphibulkij, K., Teo, W. S., Lim, H. M., Zou, L., Ong, C. N., Alberts, R., Chen, J., & Lim, L. H. K. (2022) · Theranostics · doi:10.7150/thno.68611 · Cited by 18
Luan, B., Ge, F., Lu, X., Li, Z., Zhang, H., Wu, J., Yang, Q., Chen, L., Zhang, W., & Chen, W. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-023-03373-5 · Cited by 20
Obesity, dysbiosis and inflammation: interactions that modulate the efficacy of immunotherapy
Yende, A. S., & Sharma, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1444589 · Cited by 22
Luo, L., Zheng, W., Chen, C., & Sun, S. (2021) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000001108 · Cited by 16
Extracellular vesicles in the treatment and diagnosis of breast cancer: a status update
Zhang, X., Wang, C., Yu, J., Bu, J., Ai, F., Wang, Y., Lin, J., & Zhu, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1202493 · Cited by 21
Desalegn, Z., Smith, A., Yohannes, M., Cao, X., Anberber, E., Bekuretsion, Y., Assefa, M., Bauer, M., Vetter, M., Kantelhardt, E. J., et al. (2023) · Cancers · doi:10.3390/cancers15194893 · Cited by 18
Extracellular vesicle-mediated drug delivery in breast cancer theranostics
Abdul‐Rahman, T., Roy, P., Herrera‐Calderón, R. E., Khidri, F. F., Omotesho, Q. A., Rumide, T. S., Fatima, M., Roy, S., Awuah, W. A., Atallah, O., et al. (2024) · Discover Oncology · doi:10.1007/s12672-024-01007-y · Cited by 18
Social Isolation and Breast Cancer
Hilakivi-Clarke, L. A., & Andrade, F. D. O. (2023) · Endocrinology · doi:10.1210/endocr/bqad126 · Cited by 23
Lin, S., Zhou, Z., Qi, Y., Chen, J., Xu, G., Shi, Y., Yu, Z., Li, M., & Chai, K. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-023-03367-3 · Cited by 19
Wasiak, J., Głowacka, P., Pudlarz, A. M., Pieczonka, A. M., Dzitko, K., Szemraj, J., & Witusik‐Perkowska, M. (2024) · Molecules · doi:10.3390/molecules29102292 · Cited by 17
The animal's microbiome and cancer: A translational perspective
Aluai‐Cunha, C., Pinto, C. A., Correia, A., Serra, C. R., & Santos, A. A. F. (2023) · Veterinary and Comparative Oncology · doi:10.1111/vco.12892 · Cited by 17
Hu, P., Henry, J., Tiesman, J. P., Parlov, M., Bacon, R., Charbonneau, D. L., Venkataraman, A., Locker, K. C. S., Krigbaum, H., & Schwartz, J. R. (2024) · International Journal of Cosmetic Science · doi:10.1111/ics.12933 · Cited by 24
Targeting systemic and gut microbial metabolism in ER+ breast cancer
Heath, H., Mogol, A. N., Casiano, A. S., Zuo, Q., & Madak‐Erdogan, Z. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.12.008 · Cited by 18
Body Microbiota and Its Relationship With Benign and Malignant Breast Tumors: A Systematic Review
Samkari, A., Alsulami, M., Bataweel, L. A., Altaifi, R., Altaifi, A., Saleem, A., Farsi, A., Iskanderani, O. F., Akeel, N. Y., Malibary, N., et al. (2022) · Cureus · doi:10.7759/cureus.25473 · Cited by 19
Moving with the Times: The Health Science Alliance (HSA) Biobank, Pathway to Sustainability
Quinn, C. M., Porwal, M., Meagher, N. S., Hettiaratchi, A., Power, C. A., Jonnaggadala, J., McCullough, S., Macmillan, S., Tang, K., Liauw, W., et al. (2021) · Biomarker Insights · doi:10.1177/11772719211005745 · Cited by 16
Microbiome-targeted nanoplatforms and engineering approaches in breast cancer therapy
Sabeel, Z., & Zhao, Y. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02456-x · Cited by 21
Breast cancer but not the menopausal status is associated with small changes of the gut microbiota
Żeber‐Lubecka, N., Kulecka, M., Jagiełło-Gruszfeld, A., Dąbrowska, M., Kluska, A., Piątkowska, M., Bagińska, K., Głowienka, M., Surynt, P., Tenderenda, M., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1279132 · Cited by 16
Wei, L., Gu, C., Chen, Z., Xue, S., Wu, H., & Zeng, L. (2024) · BMC Cancer · doi:10.1186/s12885-024-12721-9 · Cited by 17
Iraji, A., Nouri, A., Edraki, N., Pirhadi, S., Khoshneviszadeh, M., & Khoshneviszadeh, M. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115359 · Cited by 14
Does Gut-breast Microbiota Axis Orchestrates Cancer Progression?
Marino, M. M., Nastri, B. M., D’Agostino, M., Risolo, R., Angelis, A. D., Settembre, G., Rienzo, M., D’Esposito, V., Abbondanza, C., Formisano, P., et al. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530322666220331145816 · Cited by 14
Melatonin: A Potential Antineoplastic Agent in Breast Cancer
Samanta, S. (2022) · Journal of Environmental Pathology Toxicology and Oncology · doi:10.1615/jenvironpatholtoxicoloncol.2022041294 · Cited by 16
Jourquin, J., Reffey, S. B., Jernigan, C., Levy, M. A., Zinser, G. M., Sabelko, K. A., Pietenpol, J. A., & Sledge, G. W. (2019) · JCO Precision Oncology · doi:10.1200/po.19.00184 · Cited by 14
Fecal microbial transplants as investigative tools in cancer
Bohm, M. S., Ramesh, A. V., Pierre, J. F., Cook, K. L., Murphy, E. A., & Makowski, L. (2024) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00171.2024 · Cited by 15
Periodontitis as a Risk Factor for Breast Cancer – What We Know Till Date?
Issrani, R., Reddy, R. J., El‐Metwally, T. H., & Prabhu, N. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.10.3109 · Cited by 15
Interaction between the breast tumor microenvironment and gut microbiome
Tang, G., Millar, E. K. A., Graham, P., & Beretov, J. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2514136 · Cited by 15
Jiang, Y., Gong, W., Xian, Z., Xu, W., Hu, J., Ma, Z., Dong, H., Lin, C., Fu, S., & Chen, X. (2023) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2023.101927 · Cited by 14
The oral-gut microbiome axis in breast cancer: from basic research to therapeutic applications
Huang, L., Jiang, C., Yan, M., Wan, W., Li, S., Xiang, Z., & Wu, J. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1413266 · Cited by 14
Altrawy, A., Khalifa, M. M., Abdelmaksoud, A., khaled, Y., Saleh, Z. M., Sobhy, H., Abdel-Ghany, S. E., Alqosaibi, A. I., Almuhanna, A., Almulhim, J., et al. (2024) · Cancers · doi:10.3390/cancers16244132 · Cited by 15
The impact of modulating the gastrointestinal microbiota in cancer patients
Morkūnas, E., Skiecevičienė, J., & Kupčinskas, J. (2020) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2020.101700 · Cited by 14
Does the gut microbiome environment influence response to systemic breast cancer treatment?
Bruce, E., Makaranka, S., Urquhart, G., & Elsberger, B. (2021) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2021.00051 · Cited by 17
Gut microbiota: Role and Association with Tumorigenesis in Different Malignancies
Ali, A., Ara, A., & Kashyap, M. K. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07357-6 · Cited by 12
Huskey, A. L. W., McNeely, I., & Merner, N. D. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.702889 · Cited by 13
Zeppa, S. D., Natalucci, V., Agostini, D., Vallorani, L., Amatori, S., Sisti, D., Rocchi, M., Pazienza, V., Perri, F., Villani, A., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1225645 · Cited by 11
Mahno, N. E., Tay, D. D., Khalid, N. S. A., Yassim, A. S. M., Alias, N., Termizi, S. A., Kasian, J., Mokhtar, N. M., & Ahmad, H. F. (2023) · Indian Journal of Microbiology · doi:10.1007/s12088-023-01135-z · Cited by 14
Effects of gut microbiota in breast cancer
Kang, L., Chen, H., He, C., & Li, J. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1617410 · Cited by 14
Bairi, K. E., Jabi, R., Trapani, D., Boutallaka, H., Bencheikh, B. O. A., Bouziane, M., Amrani, M., Afqir, S., & Maleb, A. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1758063 · Cited by 12
The gut microbiota-obesity axis in the pathogenesis and prognosis of breast cancer
Zhang, H. F., Wang, Y., Ning, B., Wang, Y., Sun, T., & Xu, J. (2026) · Annals of Medicine · doi:10.1080/07853890.2025.2611203 · Cited by 11
The Human OncoBiome Database: A Database of Cancer Microbiome Datasets
Nadia, N., & Ramana, J. (2019) · Current Bioinformatics · doi:10.2174/1574893614666190902152727 · Cited by 10
Clinical Informatics Approaches to Understand and Address Cancer Disparities
Chaunzwa, T. L., del Rey, M. Q., & Bitterman, D. S. (2022) · Yearbook of Medical Informatics · doi:10.1055/s-0042-1742511 · Cited by 10
Gut Microbiome of Patients With Breast Cancer in Vietnam
Nguyen, S. M., Tran, H. T.-T., Long, J., Shrubsole, M. J., Cai, H., Yang, Y., Nguyen, L. M., Nguyen, G. H., Nguyen, C. V., Ta, T. V., et al. (2024) · JCO Global Oncology · doi:10.1200/go.23.00234 · Cited by 15
Precision modification of the human gut microbiota targeting surface-associated proteins
Marcos-Fernández, R., Ruíz, L., Blanco‐Míguez, A., Margollés, A., & Sánchez, B. (2021) · Scientific Reports · doi:10.1038/s41598-020-80187-3 · Cited by 14
Roberto, M., Carconi, C., Cerreti, M., Schipilliti, F. M., Botticelli, A., Mazzuca, F., & Marchetti, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.704942 · Cited by 10
Jiang, R., Wang, T., Lan, Q., Qin, Y.-C., Man, T.-T., Sun, H., Li, Z.-L., Zhong, X.-T., Mo, C.-M., & Rong, Z. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02543-9 · Cited by 11
O impacto da disbiose na progressão do câncer de mama
de Castro, L. R. M., Silveira, G. F., Fraga, I. A. C., Santos, L. P. L., Ferreira, P. A., & Castro, A. M. D. (2021) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e6645.2021 · Cited by 10
Bacteriophages: unlocking a new frontier in breast cancer management by defeating oncogenic bacteria
Ramadan, Y. N., Rashed, Z. I., Ahmed, R. F., Salem, H. A., Alshareef, H. M., Ahmed-Abakur, E. H., Alanazi, F. E., Elfadil, H., & Hetta, H. F. (2025) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-025-00825-3 · Cited by 11
Bahuguna, A., & Dubey, S. K. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188956 · Cited by 11
Bose, D., Banerjee, S., Singh, R. K., Wise, L. M., & Robertson, E. S. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03203-4 · Cited by 11
Gut Microbiome: An Intersection between Human Genome, Diet, and Epigenetics
Muhammad, A. Y., Amonov, M., Baig, A. A., & Alvi, F. J. (2024) · Advanced Gut & Microbiome Research · doi:10.1155/2024/6707728 · Cited by 15
Marwaha, A., Morris, J. A., & Rigby, R. J. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109530 · Cited by 10
Kunasegaran, T., Balasubramaniam, V. R. M. T., Arasoo, V. J. T., Palanisamy, U. D., Tan, Y. K., & Ramadas, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-57627-5 · Cited by 12
Microbiota-associated mechanisms in colorectal cancer
González, A., Fullaondo, A., & Odriozola, A. (2024) · Advances in genetics · doi:10.1016/bs.adgen.2024.05.002 · Cited by 8
Ghosh, R., Sil, D., Sharma, R. R., Kumar, D., Komal, K., Kumar, S., Mahajan, H. S., Sharma, M., & Kumar, M. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10626-9 · Cited by 9
Obesity and cancer: unravelling the microbiome’s hidden role
Gaskell, C., MacDonald, R. S., Aleem, E. A., & Bendriss, G. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1602603 · Cited by 11
The association between adherence to MIND diet and risk of breast cancer: A case–control study
Sheikhhossein, F., Imani, H., Amini, M. R., Hosseini, F. S., & Shab‐Bidar, S. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14780 · Cited by 9
Puig-Saenz, C., Pearson, J. R. D., Thomas, J. E., & McArdle, S. (2023) · Biomedicines · doi:10.3390/biomedicines11082100 · Cited by 11
Sajjad, A., Ali, S., Mumtaz, S., Summer, M., Farooq, M. A., & Hassan, A. H. (2024) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2024.02.023 · Cited by 9
Nanomedicines via the pulmonary route: a promising strategy to reach the target?
Guérin, M., & Lepeltier, É. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01590-1 · Cited by 10
Metabolomic Discovery of Microbiota Dysfunction as the Cause of Pathology
Nv, B., Grechko, A. V., & Olenin, A. Y. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.87176 · Cited by 9
Cohabitation, infection and breast cancer risk
Kinlen, L. J., Gilham, C., Ray, R. M., Thomas, D. B., & Peto, J. (2020) · International Journal of Cancer · doi:10.1002/ijc.33319 · Cited by 10
Oral Abundance of Actinomyces spp. in Breast Cancer Patients
Bilgilier, C., Fuereder, T., Kastner, M.-T., Vass, Z., Brandl, I., Sahbegovic, H., Singer, C. F., & Steininger, C. (2022) · Oncology · doi:10.1159/000522070 · Cited by 10
Kibria, M. K., Ali, M. A., & Mollah, M. N. H. (2024) · PLoS ONE · doi:10.1371/journal.pone.0312493 · Cited by 7
Kibria, M. K., Sifat, I. K., Hossen, M. B., Hasan, F., Mosharaf, M. P., & Hassan, M. Z. (2024) · The Microbe · doi:10.1016/j.microb.2024.100228 · Cited by 7
Metadata
- Authors
- Fernández, M. F., Reina-Pérez, I., Astorga, J. M., Rodríguez-Carrillo, A., Plaza-Díaz, J., & Fontana, L.
- Affiliations
- Universidad de Granada (ES)
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES)
- Department of Radiology, School of Medicine, and Biomedical Research Center, University of Granada, 18071 Granada, Spain
- Health Research Institute of Granada (ibs.GRANADA), 18010 Granada, Spain
- Corresponding author
- Fernández, Mariana F.
- Fontana, Luis
- Venue
- International Journal of Environmental Research and Public Health
- Publisher
- MDPI AG
- Published
- 2018-08-14
- Volume
- 15
- Issue
- 8
- Pages
- 1747
- ISSN
- 1660-4601 (ISSN-L)
- PMC
- PMC6121903
- OpenAlex
- W2885273732
- Cited by
- 350
- References
- 98
- Citations by year
- 2026: 22 · 2025: 38 · 2024: 51 · 2023: 48 · 2022: 46 · 2021: 70 · 2020: 47 · 2019: 24 · 2018: 2
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Environmental Research and Public Health (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Consejería de Salud, Junta de Andalucía (PI-0538-2017)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- breast cancer, gut microbiota, dysbiosis, estrogen metabolism, estrogenic compounds, cancer risk assessment, cancer prevention, tumor response, host-microbe interactions
- MeSH terms
- Gastrointestinal Microbiome, Breast Neoplasms, Estrogens, Female, Humans, Microbiota, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.